OpenAlex
PricingAboutJobs
Log inGet started
Work

CRISPR-Cas9: a prominent genome editing tool in the management of inherited blood disorders and hematological malignancies

HTML

Year: 2025
Type: review
Source: Current Research in Translational Medicine
DOI: 10.1016/j.retram.2025.103531
Authors: Ghazaleh Behrouzian Fard, Mohammad Hossein Ahmadi, Mehran Gholamin, Mahdi Hosseini Bafghi
Institution: Mashhad University of Medical Sciences
Language: English

Topic: CRISPR and Genetic Engineering
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: CRISPR/Cas9, genome editing, inherited blood disorders, sickle cell disease, beta-thalassemia, Fanconi anemia, hematologic malignancies, allogeneic hematopoietic stem cell transplantation, ex vivo gene therapy, autologous hematopoietic stem cells, chimeric antigen receptor T cells, off-target effects, immunogenicity
SDG: Good health and well-being

Open Access status: closed

Funder: Mashhad University of Medical Sciences
OpenAlex ID: W4412678122
FWCI: 0.283
Cites: 127
Cited by: 6
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms